Source: Fortune
Summary
Moderna cofounder Robert Langer’s net worth rose to $1.7 billion after the company’s stock surged following positive cancer vaccine trial results. Langer’s equity in Moderna, which accounts for roughly 3% of the company, doubled in value. This marks his second time entering the billionaires club, after a surge in 2020 linked to the company’s COVID-19 vaccine. Forbes analyzed the increase, noting the stock’s more than 100% jump. Langer, 77, has long emphasized the importance of meaningful work over financial gain, according to past interviews.
Our Reading
The numbers tell one story.
Moderna’s stock jumped 100% after positive trial results.
Langer’s stake went from $730 million to $1 billion.
He’s a billionaire again, but still talks about purpose over pay.
The story of a scientist who turned down oil money for impact.
Author: Evan Null
Langer turned down 20 job offers to chase his dreams—he advises workers not to ‘give up too easily’
Robert Langer, the Moderna cofounder, turned down 20 high-paying job offers in the 1970s to pursue a career in biotechnology. At the time, oil companies were offering lucrative positions, but Langer was more interested in making a broader impact. His decision to forgo these roles set him on a path that would eventually lead to the creation of Moderna. Langer’s journey shows the long-term rewards of sticking with a vision, even when the immediate financial returns are not clear. He continues to advocate for young professionals to prioritize meaningful work over job security and money.
Langer’s early career was not without challenges. After rejecting the oil industry offers, he joined a lab at Boston Children’s Hospital, where he worked on drug delivery systems. His research was groundbreaking, but it was not immediately accepted by the scientific community. Langer faced multiple rejections for grants and struggled to find a permanent position in chemical engineering. Eventually, he found a role in a nutrition department, though it was not a perfect fit. His persistence paid off when he joined MIT and built one of the largest biomedical engineering labs in the world.
Langer’s career took a major turn in 2010 when he cofounded Moderna. The company’s development of the mRNA vaccine for COVID-19 catapulted it into the spotlight and made Langer a billionaire again. His work on the melanoma vaccine has now pushed his net worth to $1.7 billion. Despite his financial success, Langer remains focused on the impact of his work, not the money. He continues to encourage young professionals to follow their passions, even if it means taking risks and facing setbacks along the way.
Langer’s story is a testament to the value of perseverance and vision. He faced rejection and uncertainty but never gave up on his goals. His advice to young workers is to stay open-minded and not be afraid to challenge the status quo. Langer believes that the most fulfilling careers come from a deep sense of purpose, not just financial gain. His journey shows that success often comes after years of hard work, setbacks, and a commitment to making a difference.
As Moderna continues to advance its research in cancer treatment, Langer’s influence remains strong. His legacy is not just in the billions he has earned, but in the inspiration he provides to others. He has shown that it is possible to build a career that is both impactful and personally rewarding. Langer’s message is clear: don’t give up too easily, and always pursue what truly matters to you.
Even after turning down 20 high-paying job offers, Langer was met with rejection
Despite his early success in rejecting high-paying oil industry jobs, Langer faced further challenges in his career. After joining Judah Folkman’s lab, he encountered skepticism from the scientific community. His research on drug delivery systems was considered too novel, and he struggled to secure funding. Langer’s first nine grant applications were rejected, and he found it difficult to find a permanent position in chemical engineering. He eventually took a role in a nutrition department, where his work was not always valued. This period of rejection and uncertainty tested his resolve, but he continued to push forward.
Langer’s persistence eventually led to a faculty position at MIT in 1978, where he built one of the largest biomedical engineering labs in the world. His work in drug delivery systems laid the foundation for future breakthroughs, including the development of mRNA technology. Langer’s journey from rejection to academic success highlights the importance of perseverance in the face of adversity. It also underscores the value of staying true to one’s vision, even when the path is not clear.
The challenges Langer faced early in his career were not unique to him. Many scientists and innovators encounter resistance when they challenge conventional thinking. Langer’s experience shows that success often comes after years of hard work, setbacks, and a willingness to take risks. His story is a reminder that the most impactful careers are often built on a foundation of resilience and a commitment to making a difference.
Langer’s advice to young professionals is rooted in his own experiences. He encourages them to be open-minded, persistent, and willing to take risks. He believes that the most fulfilling careers come from a deep sense of purpose, not just financial gain. His message is clear: don’t give up too easily, and always pursue what truly matters to you.
As Moderna continues to advance its research in cancer treatment, Langer’s influence remains strong. His legacy is not just in the billions he has earned, but in the inspiration he provides to others. He has shown that it is possible to build a career that is both impactful and personally rewarding. Langer’s message is clear: don’t give up too easily, and always pursue what truly matters to you.
